Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Neuroblastoma

What is Neuroblastoma?

Neuroblastoma is a rare form of extracranial solid cancer found in children.

 

Neuroblastoma is a rare form of extracranial solid cancer found in children.
Acknowledgement of Neuroblastoma has not been added yet.
10.0http://www.orpha.net
Synonyms for Neuroblastoma has not been added yet.
Cause of Neuroblastoma has not been added yet.
Symptoms for Neuroblastoma has not been added yet.
Diagnosis of Neuroblastoma has not been added yet.
Diagnostic tests of Neuroblastoma has not been added yet
Treatments of Neuroblastoma has not been added yet.
Prognosis of Neuroblastoma has not been added yet.
Tips or Suggestions of Neuroblastoma has not been added yet.
References of Neuroblastoma has not been added yet.
Possible Subject Line: 30-Year-Old NB Survivor-Eager to help u, listen! Created by Mariah1800
Last updated 3 Jul 2009, 03:07 AM

Posted by Mariah1800
3 Jul 2009, 03:07 AM

My name is Mariah and I am a 30-year-old neuroblastoma survivor. At the age of 1, I was diagnosed, and I had a tumor wrapped around my spine and aorta. At the time, there was nothing that could be done for me, so my parents agreed to let me be an experimental patient at Mayo Clinic in Rochester, Minnesota. The cancer was cured after many years of chemotherapy, radiation, and surgeries!!! Even though I am cured, I have had a lifetime of secondary medical effects from the treatments. I have had a wide array of issues that have popped up, and I continue to battle them. Currently, I am disabled because of back issues (because of the location of the tumor, I had scoliosis, which led to back braces and multiple surgeries) and chronic pain, as well as some other issues. Although I do have these other issues, I am very thankful to be alive! I did go to college and graduate schools - I have a bachelor's degree in political science and a master's degree in business administration. I did, however, study biology and chemistry for a few years, so coupled with my 29 years of medical experience, I can maybe offer some layperson help with any medical issues that you might have. Since I am unable to work, I would LOVE to be able to help any of you with trying to understand medical questions...I also am a very good listener (my friends all come to me for help and advice) and would love to hear your stories, as well as offer some support...And, I would love to be able to offer you hope that things can work out and this cancer can be cured!!

Community External News Link
Title Date Link
Ascentage Pharma's MDM2-p53 Inhibitor Alrizomadlin (APG-115) Granted Rare Pediatric Disease Designation By The US FDA For The Treatment Of Neuroblastoma 03/27/2022
Community Resources
Title Description Date Link

Clinical Trials


Cords registry

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access.

Enrolling is easy.

  1. Complete the screening form.
  2. Review the informed consent.
  3. Answer the permission and data sharing questions.

After these steps, the enrollment process is complete. All other questions are voluntary. However, these questions are important to patients and their families to create awareness as well as to researchers to study rare diseases. This is why we ask our participants to update their information annually or anytime changes to their information occur.

Researchers can contact CoRDS to determine if the registry contains participants with the rare disease they are researching. If the researcher determines there is a sufficient number of participants or data on the rare disease of interest within the registry, the researcher can apply for access. Upon approval from the CoRDS Scientific Advisory Board, CoRDS staff will reach out to participants on behalf of the researcher. It is then up to the participant to determine if they would like to join the study.

Visit sanfordresearch.org/CoRDS to enroll.

Community Leaders

 

Expert Questions

Ask a question

Community User List

30-Year-Old Neuroblastoma Survivor

 

-Diagnosed in 1980 at the age of 1 with a tumor wrapped around my spine and aorta. At the time, there was nothing that could be done. Luckily, we lived near...
I am a Wife and Mother of a 7 year old girl who has been diagnosed with Ganglioneuroblastoma Cancer and ROHHAD Syndrome.

 

 

My daughter began showing symptoms that something was wrong...
I was diagnosed with neuroblastoma in 1975 when I was six months old. While I survived, the radiation therapy stunted my growth, and some of the neurological damage was irreversible. Currently I...

Start a Community


Don't See Your Condition On Rareshare?

Start your own! With a worldwide network of 8,000 users, you won't be the only member of your community for long.

FAQ


Have questions about rareshare?

Visit our Frequently Asked Questions page to find the answers to some of the most commonly asked questions.

Discussion Forum


Communities

Our Communities

Join Rareshare to meet other people that have been touched by rare diseases. Learn, engage, and grow with our communities.

FIND YOUR COMMUNITY
Physicians

Our Resources

Our rare disease resources include e-books and podcasts

VIEW OUR EBOOKS

LISTEN TO OUR PODCASTS

VIEW OUR GUIDES

Leaders

Our Community Leaders

Community leaders are active users that have been touched by the rare disease that they are a part of. Not only are they there to help facilitate conversations and provide new information that is relevant for the group, but they are there for you and to let you know you have a support system on Rareshare.